Camille Bedrosian Insider Profile

4 Followers
Camille Bedrosian, VP, Chief Medical Officer at Ariad, holds 0.00 shares in Ariad (Ticker: ARIA), holds 35.79K shares in Ultragenyx Pharmaceutical (Ticker: RARE), holds ― shares in Crinetics Pharmaceuticals (Ticker: CRNX). Most recently, Camille Bedrosian ― shares of Ariad on ― for an estimated value of ―.
tipranks
Camille Bedrosian

Camille Bedrosian
Ariad (ARIA)
VP, Chief Medical Officer

Not Ranked
Camille Bedrosian has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
100.00%
0.00%
A breakdown of Camille Bedrosian's holdings

Insider Roles

Ultragenyx Pharmaceutical
(RARE)
EVP and Chief Medical Officer
Crinetics Pharmaceuticals
(CRNX)
Director
Roles that Camille Bedrosian holds in companies

Most Profitable Insider Trade

Stock:
Ultragenyx Pharmaceutical
(RARE)
Rating:Informative Sell
Date:Oct 16, 2020 - Oct 16, 2021
Return:-33.10%
The most profitable trade made by Camille Bedrosian

Camille Bedrosian's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ARIA
Ariad
$0.00
Ultragenyx Pharmaceutical
Oct 16, 2020
EVP and Chief Medical Officer
Informative Sell
23.06K
$4.38M
Crinetics Pharmaceuticals
Director
List of latest transactions for each holding click on a transaction to see Camille Bedrosian's performance on stock

Camille Bedrosian insider profile FAQ

What is the percentage of profitable transactions made by Camille Bedrosian?
The percentage of profitable transactions made by Camille Bedrosian is ―.
    What is the average return per transaction made by Camille Bedrosian?
    The average return per transaction made by Camille Bedrosian is ―.
      What stocks does Camille Bedrosian hold?
      Camille Bedrosian holds: ARIA, RARE, CRNX stocks.
        What was Camille Bedrosian’s latest transaction?
        Camille Bedrosian latest transaction was an Uninformative Buy of ―.
          What was Camille Bedrosian's most profitable transaction?
          Camille Bedrosian’s most profitable transaction was an Informative Sell of RARE stock on October 16, 2020. The return on the trade was -33.10%.
            What is Camille Bedrosian's role in Ariad?
            Camille Bedrosian's role in Ariad is VP, Chief Medical Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.